Purpose: Legionella is a common cause of community-acquired pneumonia (CAP) and is second only to Pneumococcal pneumonia as a cause of severe CAP that requires treatment in an intensive care unit. We report a case series of patients with severe Legionella pneumonia who developed the acute respiratory distress syndrome (ARDS), failed to improve with mechanical ventilation alone and required extracorporeal life support (ECLS). Methods: We performed a retrospective study of all patients treated with ECLS at our institution for severe ARDS as a result of Legionella pneumonia from 1994 to 2006.
Introduction
Since the first known outbreak of Legionnaires' disease at a 1976 meeting of the Pennsylvania Chapter of the American Legion, Legionella have been recognized as a common cause of community-acquired pneumonia. 1, 2 Cigarette smoking, chronic lung disease and immunosuppression have been implicated as risk factors for the development of severe Legionella pneumonia. 3, 4 Legionella pneumonia is often clinically and radiographically similar to other forms of pneumonia, although presentations may range from mild flu-like symptoms to a fulminating course complicated by multiple organ failure. The species Legionella pneumophila accounts for 85-90% of cases and is separated into over 40 serogroups (of which serogroups 1, 4 and 6 most commonly cause illness). 5 The severity of the disease is often determined by the patient's immunocompetency as well as the timeliness of appropriate antibiotic treatment. 6, 7 Those patients admitted to the ICU for severe Legionella pneumonia have a mortality rate of 33%. 8 Extracorporeal life support (ECLS) is an established option for treating severe ARDS for various etiologies when mechanical ventilation fails. 9 In one series of thirteen patients treated for Legionella-related ARDS with ECMO at a major UK ECLS center from 1989 to 1998, seven survived. 10 Of those patients in that series who were confirmed to have Legionella pneumonia, only two survived (25%). Four other groups have reported single cases in which ECLS was successfully used to treat a patient with ARDS complicating legionellosis. [11] [12] [13] [14] 
Methods
We reviewed the medical records of those adult patients treated with ECLS for ARDS secondary to Legionella pneumonia at our institution between 1994 and 2006. These twelve patients represent a small fraction of all patients treated for Legionella pneumonia over that same time period; while most were successfully managed with conventional ventilation, these twelve failed maximal ventilator management and met the institution's criteria for ECLS (listed in Table 1 ). 15 This study was approved by our institution's Institutional Review Board.
We collected data on demographics, comorbidities, hemodynamic parameters and ventilatory support used before ECLS. Outcome measures included survival to hospital discharge, duration of ECLS, days on the ventilator, days in an intensive care unit, total length of hospital stay, adjunct therapies and procedures and complications. Descriptive statistics and Mann-Whitney U tests (to assess significance differences between survivors and non-survivors) were performed in predictive analytics software (PASW) (SPSS, Chicago, IL). All patients underwent veno-venous bypass (the standard mode of ECLS for an adult patient with respiratory failure who does not require cardiac support). Although the time between the patient's first presentation for medical attention and the actual initiation of antibiotics is a relevant factor in the treatment of legionellosis (as with other forms of pneumonia), we did not have enough information from the medical records to adequately assess this factor.
Veno-venous bypass typically involved the percutaneous placement of a 23 French venous drainage cannula within the femoral vein and a 21 French re-infusion cannula within the right internal jugular vein during the time examined. All patients require systemic heparinization to maintain an activated clotting time (ACT) between 180-200 sec. Circuit flow is maintained between 3-6 L/min. Patients are sedated and paralyzed. The patient's pulmonary mechanics are reviewed daily, as is oxygen diffusion across the native lung. Once a patient is ready to have ECLS discontinued, the circuit is temporarily clamped to allow his or her respiratory status to be fully characterized before decannulation.
Ventilator management for these patients typically consists of inverse ratio pressure-controlled ventilation with a maximum peak inspiratory pressure of 30 mmHg and a positive end expiratory pressure (PEEP) usually maintained at 10 mmHg. The fraction of inspired oxygen (FiO 2 ) is maintained at 30 to 40%, if possible. This ventilator strategy helps to minimize both pressure-related lung injury and oxygen toxicity during ECLS.
Results
Between 1994 and 2006, twelve patients (three women and nine men) with an average age of 47.0 ± 7.7 years (range 33-57 years) were treated with VV ECLS for severe Legionella pneumonia at our institution (as diagnosed on urine Legionella antigen at our institution or their referring institution). Their demographic characteristics are summarized in Table 2 . Eight patients (67%) had co-morbid illnesses, the most common being diabetes (4/12, 33%). Six patients (50%) had a smoking history. Seven patients (58%) had an elevated creatinine on admission and were classified as having renal failure. One patient had a history of breast cancer treated with resection, radiation and autologous stem-cell transplant four years prior to her treatment with ECLS; she had no evidence of recurrent disease at that time. All seven of these patients required continuous renal replacement therapy during ECLS. The survival among this sub-set of patients was 43%.
ECLS became necessary for all of these twelve patients due to worsening oxygenation. For four patients (33%), clinical deterioration was so rapid that ECLS was started within 24 hours of intubation. The others were treated with one to seven days of mechanical ventilation before ECLS. The clinical course of these twelve patients is briefly summarized in Table 3 . Of the twelve patients, nine (75%) recovered enough lung function for ECLS to be stopped. Survival to hospital discharge for all twelve patients was 67%. Two patients (13%) died of sepsis and multisystem organ failure while on ECLS. One patient (8%) was diagnosed with global hypoxic encephalopathy. One patient (8%) with a history of alcoholic cirrhosis was able to be successfully weaned from ECLS, but ultimately died from liver failure before hospital discharge. These patients underwent an average of 283 ± 168 hours of ECLS. Those who survived to discharge under-went an average of 189 ± 71 hours of ECLS, while those who did not survive underwent 472 ± 142 hours. This difference was statistically significant (U = 1.0, p = 0.011). The mean length of stay was 25.5 ± 14.2 days.
Eleven of the twelve (92%) patients underwent a tracheostomy. Ten of these were performed while the patient was on ECLS, at an average of 2.9 ± 1.9 days after initiation of ECLS. Seven of the twelve patients (58%), including the four patients who died before discharge, required continuous renal replacement therapy.
The surviving patients did not differ significantly from those who died in the number of days spent on the ventilator prior to ECLS therapy (mean 1.6 ± 2.4 vs. 1.8 ± 1.0 days; U = 11, p = 0.38). The mean age of those who survived was 41 ± 6 years, significantly lower than the mean age of those who died (53 ± 3 years; U = 1.5, p = 0.013). Four patients had bleeding complications related to the anticoagulation necessary for ECLS. Two had isolated bleeding at ECLS cannulation sites, one had bleeding from the tracheostomy site and the fourth had intra-abdominal bleeding, causing abdominal compartment syndrome (stemming from a previous laparoscopic cholecystectomy).
Discussion
Patients with Legionella pneumonia who require ICU admission and the use of mechanical ventilation have a high mortality rate. Three studies reported mortality rates of 30, 33, and 36% among patients with legionellosis in the ICU. 6, 8, 16 ECLS for the treatment of ARDS stemming from Legionella pneumonia has been described in case reports and a series of thirteen cases. This is the largest series of confirmed cases of Legionella pneumonia requiring ECLS. Of twelve such patients, 75% were able to be weaned from ECLS and 67% survived to hospital discharge. The most common complication was renal failure (58% of patients required hemodialysis). These patients spent an average of 12 days on ECLS and had a mean length of stay of 26 days.
Survival rates for adult patients requiring ECLS vary according to the etiology of cardio-respiratory failure. In adult patients receiving ECLS for cardiac support, studies have reported survival rates of 36% and 38%. 17, 18 Survival rates among patients undergoing ECLS for trauma have been reported at 50% and 63%. 19, 20 Survival rates for patients requiring ECLS for ARDS is 52%. 9 In this context, the 67% survival rate for our cohort with legionellosis is noteworthy. In contrast, Ichiba et al. found substantially lower survival for the sub-set of Legionella pneumonia cases requiring ECLS (25% survival for confirmed cases and 54% for suspected cases, compared with 64% overall survival for all ARDS patients receiving ECLS). 10 The majority of patients who failed conventional management within our review had a rapid progression from hospital admission to maximal ventilator support. We speculate that ECLS is most successful if started when the patients are in the early stages of a precipitous decline, reducing the damage from ventilator-induced lung injury. Patients, of course, worsen at varying speeds and begin ECLS at various stages in their illness, which prevents us from inferring anything more concrete on this topic.
Veno-venous (VV) ECLS was used in all twelve cases, since these patients experienced respiratory distress only and did not require cardiac support. VV ECLS has been shown to be sufficient support in previous series of adults undergoing ECLS for purely respiratory indications, while reducing neurologic complications relative to veno-arterial ECLS. 16 Comorbidities of the patients in this study included diabetes (4 patients, 33%), chronic obstructive pulmonary disease (COPD) and immunosuppression following bone marrow transplant (one each). These comorbidities are associated with worse outcomes in Legionella pneumonia. 6 Smoking, present in half of the twelve patients, is associated with the development of legionellosis and with mortality once infected. 21 Four patients had bleeding complications, ranging from minor bleeding at ECLS cannulation sites to intraabdominal bleeding causing abdominal compartment syndrome and requiring another operation. Lowering the risks due to anticoagulation remains one of the most pressing issues in the clinical use of ECLS and in research relating to ECLS.
The other noteworthy complication, acute renal failure, is commonly associated with legionellosis. Of all adults treated with ECLS at our institution from 1989 to 2003, 53.7% required some form of renal replacement therapy. 9 These patients had only 33% survival to decannulation, compared to 70% for all patients with ARDS receiving ECLS. The mortality of legionellosis increases from 15% to 53% with associated renal failure. 22 Of the seven patients with renal failure in this study, only three (43%) survived, compared to all five of those who avoided renal failure in our series. While no specific inference can be made, the negative effects of renal failure on survival appear to be reflected in this patient cohort.
Unsurprisingly, age and ECLS run time were associated with lower survival, although the small number of cases limits the conclusions that can be drawn. Also, an important consideration in judging the baseline risk of mortality for patients with any form of pneumonia, the time from clinical suspicion of pneumonia to the initiation of intravenous antibiotics, could not be examined in our data and, therefore, limits our analysis. 23 Tracheostomies and continuous hemodialysis or hemofiltration were used in a majority of patients. Early tracheostomies are consistent with generally accepted principles of ECLS, since they have been shown to reduce mortality in the critically ill. 24 Despite the increased risk of bleeding from ECLS, only one of eleven patients undergoing tracheostomy had bleeding at the tracheostomy site, suggesting that ECLS therapy should not preclude necessary procedures that may carry an increased bleeding risk.
ECLS is an established therapy for severe respiratory distress from various indications. 9, 20 This study suggests that ECLS for severe ARDS associated with Legionella pneumonia is a feasible treatment option when mechanical ventilation fails.
